Biological medical Mg-Sn-Zn alloy and rolling method thereof

A biomedical, mg-sn-zn technology, applied in metal rolling and other directions, can solve the problems that degradation products easily cause inflammation and swelling, are not biodegradable biomedical materials, and have low mechanical properties of magnesium alloys, and achieve excellent bearing capacity. and biocompatibility, excellent comprehensive mechanical properties, casting defect elimination effect

Inactive Publication Date: 2016-12-21
GUANGXI UNIVERSITY OF TECHNOLOGY
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, most biodegradable biomedical materials are polylactic acid (PLA), polyglycolic acid (PGA) and other polymer materials, but these polymer materials have low mechanical properties, and the degradation products are easy to cause inflammation and swelling, and the processing is difficult, which is not ideal. biodegradable biomedical materials
It is a new type of biomedical alloy. Compared with polymer materials, it has better load-bearing capacity and good biocompatibility. Compared with traditional metal hard tissue implant materials, magnesium alloy materials have biodegradable properties. Absorption performance, no need for secondary surgery to remove the implant material; although the biocompatibility of biodegradable biomedical magnesium alloy is better, it also has its shortcomings, compared with metal materials such as titanium alloy and cobalt-chromium alloy , the mechanical properties of magnesium alloys in the prior art are slightly low, and the corrosion rate is too fast. During use, the biological implant material will fail due to insufficient bearing capacity and too fast degradation rate, thus affecting the application of magnesium alloy biomaterials in clinical medicine. field application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biological medical Mg-Sn-Zn alloy and rolling method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] A biomedical Mg-Sn-Zn alloy with a slab size of 120×100×20mm 3 , its rolling method comprises the following steps:

[0023] The Mg-Sn-Zn alloy ingot is kept at 300°C for 12 minutes, and then the Mg-Sn-Zn alloy slab is subjected to single-pass 15% hot rolling pre-deformation at 300°C, and then continues to be heated at 300°C Carry out a single pass of 80% large-reduction rolling forming, and then carry out water-cooling treatment to room temperature. The alloy slab after water-cooling treatment is subjected to aging treatment at 150°C for 4 hours, and finally water-quenched.

[0024] The biomedical Mg-Sn-Zn alloy is composed of the following components: Sn 2.0%, Zn 0.8%, Mg 97.2%.

[0025] The casting molding of described Mg-Sn-Zn alloy billet comprises the following steps:

[0026] Melt Mg, Sn, and Zn at 740°C and cast them into Mg-Sn-Zn alloy ingots. The smelting process is protected by argon gas; then it is subjected to homogenization annealing treatment, the anneal...

Embodiment 2

[0029] The biomedical Mg-Sn-Zn alloy of the present invention has a slab size of 140×110×35mm 3 , its rolling method comprises the steps:

[0030] The Mg-Sn-Zn alloy ingot is kept at 315°C for 35 minutes, and then the Mg-Sn-Zn alloy slab is subjected to single-pass 16% hot rolling pre-deformation at 317°C, and then continues to be heated at 317°C Carry out a single pass of 86% large-reduction rolling forming, and then carry out water-cooling treatment to room temperature. The alloy slab after water-cooling treatment is subjected to aging treatment at 165°C for 6 hours, and finally water-quenched.

[0031] The biomedical Mg-Sn-Zn alloy is composed of the following components: Sn 4.0%, Zn 1.0%, Mg 95%.

[0032] The casting molding of described Mg-Sn-Zn alloy billet comprises the following steps:

[0033] Melt Mg, Sn, and Zn at 752°C and cast them into Mg-Sn-Zn alloy ingots. The smelting process is protected by argon; then it is subjected to homogenization annealing treatment, ...

Embodiment 3

[0036] A biomedical Mg-Sn-Zn alloy with a slab size of 170×135×50mm 3 , its rolling method comprises the steps:

[0037] The Mg-Sn-Zn alloy ingot was kept at 342°C for 80 minutes, and then the Mg-Sn-Zn alloy slab was subjected to single-pass 18% hot-rolling pre-deformation at 335°C, and then continued at 335°C Carry out single-pass 90% large-reduction rolling forming, and then carry out water-cooling treatment to room temperature. The alloy slab after water-cooling treatment is subjected to aging treatment at 180°C for 8 hours, and finally water-quenched.

[0038] The biomedical Mg-Sn-Zn alloy is composed of the following components: Sn 6.0%, Zn 1.2%, Mg 92.8%.

[0039] The casting molding of described Mg-Sn-Zn alloy billet comprises the following steps:

[0040] Melt Mg, Sn, and Zn at 764°C and cast them into Mg-Sn-Zn alloy ingots. The smelting process is protected by argon; then it is homogenized and annealed. The annealing temperature is 430°C and the annealing time is 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a biological medical Mg-Sn-Zn alloy and a rolling method thereof. The method comprises the following steps: keeping a Mg-Sn-Zn alloy ingot blank at the temperature of 300-350 DEG C for more than 12 minutes, carrying out single-pass 15-20% hot rolling pre-deformation at 300-350 DEG C, continuing single-pass 80-95% high reduction rolling formation at 300-350 DEG C, cooling with water to room temperature, and carrying out aging treatment on the water-cooled alloy plate blank at 150-200 DEG C for 4-10 hours, and finally, carrying out water quenching, wherein the holding time increases as the size of the plate blank increases. The invention also discloses a casting method of the Mg-Sn-Zn alloy ingot blank. The biological medical Mg-Sn-Zn alloy can be automatically degraded, has favorable carrying capacity and biocompatibility, can be widely used for preparing implantation materials in the human body, and has wide application prospects in biological medical material processes.

Description

technical field [0001] The invention relates to the field of biological materials, in particular to a biomedical Mg-Sn-Zn alloy and a rolling method thereof. Background technique [0002] With the development of medicine and material science, people hope that the materials implanted in the body will only play a temporary role in replacing them, and gradually degrade and absorb with the regeneration of tissues or organs, so as to minimize the long-term impact of implanted materials on the body. Because biodegradable materials are easy to decompose in the living body, and their decomposition products can be metabolized and finally excreted from the body, they have attracted more and more attention from the people. [0003] At present, most biodegradable biomedical materials are polylactic acid (PLA), polyglycolic acid (PGA) and other polymer materials, but these polymer materials have low mechanical properties, and the degradation products are easy to cause inflammation and sw...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C22C23/00C22F1/06B21B3/00
CPCB21B3/00B21B2003/008C22C23/00C22F1/002C22F1/06
Inventor 孙有平何江美
Owner GUANGXI UNIVERSITY OF TECHNOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products